The CEO of Corbus on nectin-4 ADCs, integrin biology, and an alternative to GLPs for weight loss
Yuval Cohen describes why he believe his company's nectin-4 ADC has a next generation design, he covers the idea of integrin inhibition for cancer, and describes the oral weight loss pill Corbus will be advancing to the clinic.